Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

BC081120

Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases/110 cores, replacing BC081115
Unstained: $255.00 Add to Cart
H&E (BC081120s*): $255.00 Add to Cart

Microarray Panel:Breast carcinoma and adjacent normal tissue microarray, containing 100 cases of invasive ductal carcinoma, 10 adjacent normal tissue, single core per case
Cores:110
Cases:110
Layout:10 cols × 11 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
B Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
C Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
D Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
E Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
F Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
G Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
H Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
I Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
J Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre  
K Bre Bre Bre Bre Bre Bre Bre Bre Bre Bre Marked point
Legend: Bre - Breast

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage IV), - NAT

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 39 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
A2 2 F 48 Breast Invasive ductal carcinoma 1 IIIb T4N0M0 Malignant
A3 3 F 43 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
A4 4 F 45 Breast Invasive ductal carcinoma 2 IIIb T4N0M0 Malignant
A5 5 F 53 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
A6 6 F 53 Breast Invasive ductal carcinoma 2 IIb T3N0M0 Malignant
A7 7 F 48 Breast Invasive ductal carcinoma 1 IIIb T4N0M0 Malignant
A8 8 F 37 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
A9 9 F 32 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
A10 10 F 32 Breast Invasive ductal carcinoma 1 IIa T1N1M0 Malignant
B1 11 F 41 Breast Invasive ductal carcinoma 1 IIIa T2N2M0 Malignant
B2 12 F 55 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
B3 13 F 67 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
B4 14 F 34 Breast Invasive ductal carcinoma 1 IIb T3N0M0 Malignant
B5 15 F 46 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
B6 16 F 49 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
B7 17 F 47 Breast Invasive ductal carcinoma 1–2 I T1N0M0 Malignant
B8 18 F 48 Breast Invasive ductal carcinoma 1 IIIb T4N2M0 Malignant
B9 19 F 52 Breast Invasive ductal carcinoma 1 IIIa T2N2M0 Malignant
B10 20 F 61 Breast Invasive ductal carcinoma 1 IIIa T2N2M0 Malignant
C1 21 F 38 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C2 22 F 45 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C3 23 F 38 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
C4 24 F 63 Breast Invasive ductal carcinoma 1 I T1N0M0 Malignant
C5 25 F 32 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C6 26 F 45 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
C7 27 F 54 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
C8 28 F 47 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
C9 29 F 51 Breast Invasive ductal carcinoma 2 IIIa T2N2M0 Malignant
C10 30 F 45 Breast Invasive ductal carcinoma (sparse) 2 I T1N0M0 Malignant
D1 31 F 40 Breast Invasive ductal carcinoma 2 I T1cN0M0 Malignant
D2 32 F 50 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D3 33 F 56 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D4 34 F 55 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D5 35 F 59 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D6 36 F 53 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
D7 37 F 57 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D8 38 F 51 Breast Invasive ductal carcinoma 2 IIb T3N1M0 Malignant
D9 39 F 64 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
D10 40 F 54 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
E1 41 F 30 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
E2 42 F 63 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E3 43 F 65 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E4 44 F 68 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E5 45 F 45 Breast Invasive ductal carcinoma 2 IIIb T4N1M0 Malignant
E6 46 F 58 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E7 47 F 42 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E8 48 F 40 Breast Invasive ductal carcinoma (sparse) – IIa T2N0M0 Malignant
E9 49 F 42 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E10 50 F 46 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
F1 51 F 39 Breast Invasive ductal carcinoma 2 IIIb T4N0M0 Malignant
F2 52 F 46 Breast Invasive ductal carcinoma (adenosis) – IIa T2N0M0 Malignant
F3 53 F 46 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
F4 54 F 46 Breast Invasive ductal carcinoma 2 IIIb T4N2M0 Malignant
F5 55 F 39 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
F6 56 F 46 Breast Invasive ductal carcinoma 2 IIb T3N0M0 Malignant
F7 57 F 32 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
F8 58 F 48 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
F9 59 F 46 Breast Invasive ductal carcinoma 2 IIIb T4N0M0 Malignant
F10 60 F 47 Breast Invasive ductal carcinoma 2 IIb T3N0M0 Malignant
G1 61 F 50 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
G2 62 F 43 Breast Invasive ductal carcinoma (sparse) 2 I T1N0M0 Malignant
G3 63 F 48 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
G4 64 F 49 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
G5 65 F 29 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
G6 66 F 40 Breast Invasive ductal carcinoma (breast tissue) – IIIb T4N2M0 Malignant
G7 67 F 38 Breast Invasive ductal carcinoma 1 I T1N0M0 Malignant
G8 68 F 38 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
G9 69 F 62 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
G10 70 F 44 Breast Invasive ductal carcinoma 1 I T1N0M0 Malignant
H1 71 F 68 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
H2 72 F 40 Breast Invasive ductal carcinoma 1 IIb T3N0M0 Malignant
H3 73 F 53 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
H4 74 F 63 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
H5 75 F 48 Breast Invasive ductal carcinoma 2 IIIb T4N1M0 Malignant
H6 76 F 62 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
H7 77 F 46 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
H8 78 F 50 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
H9 79 F 39 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
H10 80 F 60 Breast Invasive ductal carcinoma 2 IIIb T4bN1M0 Malignant
I1 81 F 41 Breast Invasive ductal carcinoma 2 IIIb T4N1M0 Malignant
I2 82 F 37 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
I3 83 F 40 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
I4 84 F 49 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
I5 85 F 50 Breast Invasive ductal carcinoma (breast tissue) – IIb T2N1M0 Malignant
I6 86 F 48 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
I7 87 F 74 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
I8 88 F 74 Breast Invasive ductal carcinoma (sparse) with plasma cell mastitis – IIa T2N0M0 Malignant
I9 89 F 40 Breast Invasive ductal carcinoma 2 IV T2N0M1 Malignant
I10 90 F 70 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
J1 91 F 64 Breast Invasive ductal carcinoma (fibrous tissue, blood vessel and tumoral necrosis) – IIa T2N0M0 Malignant
J2 92 F 52 Breast Invasive ductal carcinoma 2–3 IIb T3N0M0 Malignant
J3 93 F 35 Breast Invasive ductal carcinoma 2–3 IIa T2N0M0 Malignant
J4 94 F 53 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
J5 95 F 52 Breast Invasive ductal carcinoma 3 I T1cN0M0 Malignant
J6 96 F 41 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
J7 97 F 56 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
J8 98 F 46 Breast Invasive ductal carcinoma 3 IIIb T4N0M0 Malignant
J9 99 F 44 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
J10 100 F 38 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
K1 101 F 43 Breast Cancer adjacent normal breast tissue – – – NAT
K2 102 F 42 Breast Cancer adjacent normal breast tissue – – – NAT
K3 103 F 47 Breast Cancer adjacent normal breast tissue – – – NAT
K4 104 F 39 Breast Cancer adjacent normal breast tissue – – – NAT
K5 105 F 49 Breast Cancer adjacent normal breast tissue – – – NAT
K6 106 F 53 Breast Cancer adjacent normal breast tissue – – – NAT
K7 107 F 51 Breast Cancer adjacent normal breast tissue – – – NAT
K8 108 F 18 Breast Cancer adjacent normal breast tissue – – – NAT
K9 109 F 44 Breast Cancer adjacent normal breast tissue – – – NAT
K10 110 F 39 Breast Cancer adjacent normal breast tissue – – – NAT
– – F 55 liver Hepatocellular liver cancer (tissue marker) 3 T3N0M0 Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal